Microarray system W/analysis package
Ended Purchase Order Awarded Last action
- Contract number
- 75F40126P00037
- Awardee
-
Indevr, Inc. UEI CX4ZCPH2EAA3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $133,840
Award facts
- Contract value 100% obligated
- $133,840.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boulder, CO 80301, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Food and Drug Administration (FDA) awarded a $133,840 firm fixed price purchase order to Indevr, Inc., a small business, for a microarray system with analysis package. The contract, effective through September 30, 2026, carries a Total Small Business set aside designation. Performance will occur in Boulder, Colorado. Indevr is a specialized manufacturer of analytical technologies for vaccine characterization and production, leveraging expertise developed through prior federal contracts with the National Institutes of Health's National Institute of Allergy and Infectious Diseases and the Navy's Bureau of Medicine and Surgery.
The microarray system being procured aligns with Indevr's core capabilities in multiplex microarray assay platforms and analytical instrumentation for biotherapeutic research and development. The FDA's acquisition of this equipment supports the agency's mission to regulate vaccines and other biologics, enabling enhanced analytical capabilities for product characterization and quality assessment. This award represents the first firm fixed price contract with a small business set aside designation for Indevr, differentiating it from the company's prior federal contracting history.
Quick answers
Who was awarded contract 75F40126P00037?
75F40126P00037 was awarded to Indevr, Inc. by Food and Drug Administration (Department of Health and Human Services) on April 28, 2026.
How much is contract 75F40126P00037 worth?
The government has obligated $133,840 on 75F40126P00037.
Was contract 75F40126P00037 competed?
The extent of competition for 75F40126P00037 was competed under sap. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award